Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Berends

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Medical Genetics|December 31, 2024
Clonazepam repurposing in <i>ARID1B</i> patients through conventional RCT and N-of-1 trials: an experimental strategy for orphan disease developmentPleuntje J van der Sluijs, Koshar Safai Pour, Cécile L Berends, et al.
British Journal of Clinical Pharmacology|May 1, 2021
Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagementMichelle L Mellion, Lucienne Ronco, Cecile L Berends, et al.
Pharmacology Research & Perspectives|March 25, 2021
A novel sustained-release cysteamine bitartrate formulation for the treatment of cystinosis: Pharmacokinetics and safety in healthy male volunteersCécile L Berends, Lisa Pagan, Michiel J van Esdonk, et al.
British Journal of Clinical Pharmacology|October 10, 2022
Viral clearance, pharmacokinetics and tolerability of ensovibep in patients with mild to moderate COVID-19: A phase 2a, open-label, single-dose escalation studyManon L M Prins, Johan L van der Plas, Maurits F J M Vissers, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Medical Genetics|December 31, 2024
Clonazepam repurposing in <i>ARID1B</i> patients through conventional RCT and N-of-1 trials: an experimental strategy for orphan disease developmentPleuntje J van der Sluijs, Koshar Safai Pour, Cécile L Berends, et al.
British Journal of Clinical Pharmacology|May 1, 2021
Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagementMichelle L Mellion, Lucienne Ronco, Cecile L Berends, et al.
Pharmacology Research & Perspectives|March 25, 2021
A novel sustained-release cysteamine bitartrate formulation for the treatment of cystinosis: Pharmacokinetics and safety in healthy male volunteersCécile L Berends, Lisa Pagan, Michiel J van Esdonk, et al.
British Journal of Clinical Pharmacology|October 10, 2022
Viral clearance, pharmacokinetics and tolerability of ensovibep in patients with mild to moderate COVID-19: A phase 2a, open-label, single-dose escalation studyManon L M Prins, Johan L van der Plas, Maurits F J M Vissers, et al.
Pageof 2